Get the Stockscreener App
6.21
1.74%
-0.11
After Hours:
6.26
0.05
+0.81%
Aquestive Therapeutics Inc stock is traded at $6.21, with a volume of 1.16M.
It is down -1.74% in the last 24 hours and up +11.29% over the past month.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
See More
Previous Close:
$6.32
Open:
$6.39
24h Volume:
1.16M
Relative Volume:
0.38
Market Cap:
$757.64M
Revenue:
$58.36M
Net Income/Loss:
$-25.72M
P/E Ratio:
-17.06
EPS:
-0.3641
Net Cash Flow:
$-24.91M
1W Performance:
-2.66%
1M Performance:
+11.29%
6M Performance:
+87.61%
1Y Performance:
+68.29%
1-Day Range:
$6.19
$6.40
1-Week Range:
$5.99
$6.735
52-Week Range:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Name
Aquestive Therapeutics Inc
Sector
Phone
908-941-1900
Address
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
6.21 | 771.06M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Piper Sandler | Overweight |
| Mar-28-24 | Initiated | Raymond James | Outperform |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Apr-22-19 | Initiated | H.C. Wainwright | Buy |
| Jan-03-19 | Initiated | Lake Street | Buy |
| Aug-20-18 | Initiated | JMP Securities | Mkt Outperform |
| Aug-20-18 | Initiated | RBC Capital Mkts | Outperform |
View All
Aquestive Therapeutics Inc Stock (AQST) Latest News
Is Aquestive Therapeutics Stock Built to Withstand a Pullback? - Trefis
Pale Fire Capital SE Acquires 340,767 Shares of Aquestive Therapeutics, Inc. $AQST - MarketBeat
Looking at the Narrative for Aquestive Therapeutics After New Anaphylm Patents and FDA Momentum - Yahoo Finance
Aquestive Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Published on: 2025-12-08 02:09:31 - BỘ NỘI VỤ
Diametric Capital LP Acquires Shares of 165,373 Aquestive Therapeutics, Inc. $AQST - MarketBeat
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
What analyst consensus says on Aquestive Therapeutics Inc. stockJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser
VP Cioffi Surrenders 2,083 Of Aquestive Therapeutics Inc [AQST] - TradingView
Sio Capital Management LLC Buys 555,860 Shares of Aquestive Therapeutics, Inc. $AQST - MarketBeat
Published on: 2025-12-03 04:52:42 - Newser
Aquestive Therapeutics (AQST) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Everstar Asset Management LLC Raises Holdings in Aquestive Therapeutics, Inc. $AQST - MarketBeat
Quarterly Trades: Why Aquestive Therapeutics Inc. stock could see breakout soon - BỘ NỘI VỤ
Returns Recap: Why Aquestive Therapeutics Inc. stock could see breakout soonPrice Action & Capital Efficiency Focused Ideas - moha.gov.vn
What technical charts say about Aquestive Therapeutics Inc. stockWeekly Investment Summary & Weekly Stock Breakout Alerts - BỘ NỘI VỤ
Aquestive Therapeutics (NASDAQ:AQST) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Aquestive’s Anaphylm Shows Positive Results in First Study in Kids - Allergic Living
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
How Recent Regulatory Wins Are Shaping the Narrative for Aquestive Therapeutics - Yahoo Finance
Aquestive Therapeutics Shares Rise After $75 Million Funding Deal - MSN
Why Aquestive Therapeutics Inc. stock is favored by top institutionsTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
How to monitor Aquestive Therapeutics Inc. with trend dashboardsEarnings Risk Report & High Return Stock Watch Alerts - newser.com
Can Aquestive Therapeutics Inc. stock sustain revenue growthPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Why Aquestive Therapeutics Inc. stock is trending among retail tradersMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Aquestive Therapeutics (AQST) Price Target Increased by 14.80% to 10.51 - MSN
Aquestive Therapeutics Inc. stock momentum explainedMarket Rally & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Aquestive Therapeutics Inc.Swing Trade & Real-Time Market Sentiment Reports - newser.com
Aquestive Therapeutics (NASDAQ:AQST) Trading Up 6.5%Here's Why - MarketBeat
Officer Kraus Files To Sell 53,100 Of Aquestive Therapeutics Inc [AQST] - TradingView
Will Aquestive Therapeutics Inc. bounce back from current supportLayoff News & AI Based Buy and Sell Signals - newser.com
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Predicting Aquestive Therapeutics Inc. trend using moving averagesJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Aquestive Therapeutics’ Earnings Call: Optimism Amid Challenges - MSN
Aquestive Therapeutics (NASDAQ:AQST) Updates Amid Dow Jones Industrial Average - Kalkine Media
Why Aquestive Therapeutics Inc. stock is favored by pension fundsPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors - simplywall.st
Aquestive Therapeutics Inc Stock (AQST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aquestive Therapeutics Inc Stock (AQST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jung Cassie | Chief Operating Officer |
Oct 15 '25 |
Option Exercise |
3.10 |
25,000 |
77,568 |
308,346 |
| Jung Cassie | Chief Operating Officer |
Oct 15 '25 |
Sale |
7.01 |
67,575 |
473,701 |
240,771 |
| Kraus Carl N | Chief Medical Officer |
Oct 15 '25 |
Sale |
7.00 |
20,272 |
141,904 |
282,475 |
| Boyd Peter E. | See Remarks |
Oct 15 '25 |
Sale |
7.00 |
10,000 |
70,000 |
268,323 |
1.48%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):